SCHEMBL801438

SCHEMBL801438

O=P(c1cccc(-c2ccccc2)c1)(c1cccc(-c2ccccc2)c1)c1ccc2c(c1)c1ccccc1n2-c1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 2/20 0.50
▸ ATM Q13315 2/20 0.50
▸ KDM4E B2RXH2 1/20 0.50
▸ KMT2A Q03164 2/20 0.40
▸ NPSR1 Q6W5P4 1/20 0.38
▸ IL1R1 P14778 1/20 0.37
▸ TSPO P30536 3/20 0.36
▸ HDAC4 P56524 1/20 0.36
▸ ALDH1A1 P00352 2/20 0.36
▸ HTT P42858 2/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ FAAH O00519 1/20 0.36
▸ HSP90AA1 P07900 1/20 0.36
▸ PKM P14618 1/20 0.36
▸ MGLL Q99685 1/20 0.36
▸ MAPK8 P45983 2/20 0.34
▸ MAPK9 P45984 1/20 0.33
▸ KDR P35968 1/20 0.33
▸ MAPK1 P28482 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19444919 1.00 L3MBTL1 (0.50) L3MBTL1ATMKDM4EKMT2ANPSR1
SCHEMBL24412743 0.93 L3MBTL1 (0.49) L3MBTL1ATMKDM4EKMT2ANPSR1
SCHEMBL801100 0.93 L3MBTL1 (0.51) L3MBTL1ATMKDM4EKMT2ANPSR1
SCHEMBL801451 0.92 ATM (0.44) L3MBTL1ATMKDM4EKMT2ANPSR1
SCHEMBL801114 0.92 ATM (0.44) L3MBTL1ATMKDM4EKMT2ANPSR1
SCHEMBL801715 0.92 L3MBTL1 (0.53) L3MBTL1ATMKDM4EKMT2ANPSR1
SCHEMBL801298 0.91 KDM4E (0.56) L3MBTL1ATMKDM4EKMT2ANPSR1
SCHEMBL801297 0.91 KDM4E (0.56) L3MBTL1ATMKDM4EKMT2ANPSR1
SCHEMBL30281357 0.91 KDM4E (0.56) L3MBTL1ATMKDM4EKMT2ANPSR1
SCHEMBL11990931 0.91 KDM4E (0.60) L3MBTL1ATMKDM4EKMT2ANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9278986-B2 Carbazole-based phosphine oxide compound, and organic electroluminescent device including the same SK CHEMICALS CO., LTD. (KR) 2016-03-08 — — US disclosed
US-9278986-B2 Carbazole-based phosphine oxide compound, and organic electroluminescent device including the same SK CHEMICALS CO., LTD. (KR) 2016-03-08 — — US disclosed
US-20120068168-A1 CARBAZOLE-BASED PHOSPHINE OXIDE COMPOUND, AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME INDUSTRY-ACADEMIC COOPERATION FOUNDATION, DANKOOK UNIVERSITY (KR) 2012-03-22 — — US disclosed
US-20120068168-A1 CARBAZOLE-BASED PHOSPHINE OXIDE COMPOUND, AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME INDUSTRY-ACADEMIC COOPERATION FOUNDATION, DANKOOK UNIVERSITY (KR) 2012-03-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120068168-A1 CARBAZOLE-BASED PHOSPHINE OXIDE COMPOUND, AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME INPP5B, EZH2, PLCB3 L3MBTL1 1822/4885ATM 3758/4885KDM4E 1186/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback